The FDA has approved a drug developed at UC San Diego to treat a rare chronic disease characterized by rash, fever, chills and joint pain in patients exposed to cold temperatures, the university said March 6...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $129